-
The Commission on Case Manager Certification (CCMC) in Rolling Meadows, IL, is opening nominations to fill four commission seats. Commission candidates are self-nominated. The deadline for submitting nominations is March 15.
-
The lack of a final HIPAA security regulation means that your organization doesnt have to provide security for your patient data, right? Wrong, according to a new handbook published by URAC. Your organization already has to protect patient data under the Health Insurance Portability and Accountability Act (HIPAA) privacy rule, the book points out.
-
Despite embracing technology in many aspects of their everyday lives, people are conflicted about the impact of information technology on their health care, according to a new survey.
-
Will your facility soon be implementing the OraQuick Rapid HIV-1 Antibody Test? If so, there are several resources to help you get up to speed in offering this new service.
-
While U.S. abortion rates are dropping, particularly among teens, the decline is not equally shared among all women. Rates have increased among those who are economically disadvantaged, according to just-published research from the New York City-based Alan Guttmacher Institute (AGI).
-
Get set to add more generic oral contraceptives (OCs) to your list of available birth control options as Corona, CA-based Watson Pharmaceuticals is rolling out its brand equivalents of Ortho-Cyclen and Ortho-Novum 7/7/7, two popular pills originally developed by Raritan, NJ-based Ortho-McNeil Pharmaceutical.
-
Put syphilis detection on your radar screen: Overall rates of primary and secondary syphilis have increased slightly for the first time in more than a decade, according to a new report from the Atlanta-based Centers for Disease Control and Prevention (CDC).1
-
How many times have you tested patients to determine their HIV status, never to see them return for the test results? Get ready for that scene to change; the Food and Drug Administrations (FDA) recent approval of a new test designed to detect HIV-1 antibodies in fingerstick whole blood samples will allow you to deliver the results in about 20 minutes.
-
What if you could offer your patients a vaccine for protection against human papillomavirus (HPV), a sexually transmitted disease (STD) that can cause genital warts and cervical cancer? Just-published results from a randomized double-blind study indicates that an investigational vaccine developed by West Point, PA-based Merck & Co. reduced the incidence of human papillomavirus type 16 (HPV 16) infection in 100% of women who previously had not been infected with the STD.
-
When women enter your family planning clinic, you have a wide array of contraceptive options to offer them. But when men ask about prevention methods, you have three choices: hand them condoms, advise abstinence, or counsel on vasectomy.
